New research suggests that low-dose aspirin may help put the brakes on breast cancer. Aspirin at low levels inhibits two different lines of breast cancer cells grown in culture. One is a hard-to-treat triple-negative line. Aspirin also improves the response to tamoxifen in hormone receptor positive breast cancer cells.
Epidemiology has shown that people taking aspirin regularly are less susceptible to many different kinds of cancer, including colo-rectal, esophageal, lung, stomach, prostate, breast and even melanoma. For more details on dose, risks and benefits of aspirin, check out our free Guide to Key Aspirin Information.
[Experimental Biology 2013; American Society for Biochemistry and Molecular Biology Annual Meeting, Boston, April 20-24, 2013]
5/4/17 redirected to: https://www.peoplespharmacy.com/articles/will-aspirin-keep-barretts-from-turning-into-cancer/
